Kobo Biotech Fair Value
Kobo Biotech fair value. Kobo Biotech (KOBO) average fair value is ₹61.53 across 2 valuation models — P/B Based Valuation, Asset-Based Valuation, vs a current market price of ₹4.27 (+1340.87%), fair value range ₹23.04–₹100.01. Check Kobo Biotech networth to track the company's total market size over time.
Fair Value Analysis Export
KOBO Fair Value vs Current Price — Valuation Summary
KOBO average fair value, fair value range, price gap and valuation status across 2 models: P/B Based Valuation, Asset-Based Valuation. Explore KOBO Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
P/B Based Valuation
Asset-Based Valuation
KOBO Fair Value Analysis — Data Sources & Coverage
Kobo Biotech financial data sources, valuation methods applied and sector benchmarks used. For live price and a broader fundamental view, visit KOBO share price.
Available Data Sources: Financial statements, balance sheet data , sector comparisons.
KOBO vs Chemicals Sector Peers — P/E, P/B & Market Cap
Kobo Biotech P/E ratio, P/B ratio and market capitalisation vs Chemicals sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Mehul Colours | MEHUL | 10.07 | 1.27 | ₹53 |
| Epigral | EPIGRAL | 10.84 | 1.74 | ₹3,648 |
| PB Global | PBGLOBAL | -0.03 | 0.02 | ₹0 |
| Blue Pearl Agriventures | BPAGRI | 320.5 | 6.22 | ₹405 |
| Citurgia Biochemicals | CITURGIA | -2327.6 | -156.31 | ₹1,568 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.